Holen Sie sich die Stockscreener-App
45.31
0.15%
-0.07
Handel nachbörslich:
45.31
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen stock gains 0.39 percent after-hours to EUR 40.74 - AD HOC NEWS
Qiagen stock gets a new AI growth story from QIAGEN - AD HOC NEWS
QIAGEN N.V. (QIA) Notes AFM Disclosure on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA): BlackRock Notifies 13.04% Voting Rights - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Discloses BlackRock 12.90% Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Disclosure on BlackRock Voting Rights - TradingView
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery - Business Wire
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
Europe Point of Care Diagnostics Market Size and Forecast, 20212031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR - GlobeNewswire Inc.
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.
Qiagen NV (CEUX:QIAD) Shiller PE Ratio : (As of Oct. 03, 2026) - GuruFocus
QIAGEN N.V. (QIA): Bank of America Holds 4.95% Voting Rights - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) AFM Discloses Bank of America Voting Rights Notice - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN jumps as new FDA clearance bolsters its syndromic-testing growth story - Quiver Quantitative
Qiagen (NYSE:QGEN) Shares Climb 7.7%What's Next? - MarketBeat
Qiagen gains on report talks with potential buyer have advanced (QGEN:NYSE) - Seeking Alpha
Qiagen N.V. (1QGEN.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel - Yahoo Finance UK
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel - TradingView
A Look at Qiagen NV (QGEN) After 3.9% Decline -- GF Value $49.92 vs Price $42.04 - GuruFocus
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
QIAGEN N.V. (QIA) Notified of Bank of America Voting Rights Filing - TradingView
QIAGEN N.V. (QIA): Bank of America Discloses 5.15% Holding - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Notes AFM Filing on Voting Rights Change - TradingView
QIAGEN N.V. (QIA): Bank of America At 5.15% Stake - TradingView
QIAGEN N.V. (QIA) Discloses BlackRock Voting Rights Notification - TradingView
QIAGEN N.V. (QIA): BlackRock Holds 12.97% Voting Rights - TradingView
QIAGEN N.V. (QIA) Discloses AFM Notice on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Reports AFM BlackRock Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Reports AFM BlackRock Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Discloses AFM Notice on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Reports AFM Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Notes AFM Voting Rights Notice by BlackRock - TradingView
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel - BioBuzz
Qiagen NV (CEUX:QIAD) Cyclically Adjusted PB Ratio : (As of Sep. 29, 2026) - GuruFocus
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Preliminary Q1 2026 Qiagen NV Earnings Call Transcript - GuruFocus
Qiagen grounds drug discovery agents in curated knowledge - SiliconANGLE
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1%SNS Insider - GlobeNewswire Inc.
QIAGEN says FDA cleared second QIAstat‑Dx bloodstream panel - Mugglehead Investment Magazine
A new infection test finds 13 bacteria and 18 signs of antibiotic resistance in about an hour. - Stock Titan
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51 - MarketBeat
Warren Wise decodes Qiagen’s DNA - TradingView
2.28%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):